Early sleep and circadian markers of Alzheimer's disease: The impact of APOE-E4 on sleep/wake regulation, brain activity and cognition in humans

Project Details

StatusActive
Effective start/end date1/10/171/10/21

Funding

  • Wellcome Trust: £106,317.00